In the absence of NHMRC clinical practice guidelines for the management of ductal carcinoma in situ (DCIS), this literature review sets out the levels of evidence for using radiotherapy, mastectomy, lumpectomy and Tamoxifen to reduce the risk of: DCIS local recurrence, invasive local recurrence, metastatic disease, and death from breast cancer.
The prognosis and management of women with ductal carcinoma in situ of the breast: a review
by Ghersi, Davina|Simes, John
NHMRC National Breast Cancer Centre, Kings Cross, NSW, 1998
Categories: Breast Cancer, Precancer
Subjects: Best practice, Breast cancer, Clinical practice guidelines, Ductal carcinoma in situ, Literature reviews, Lumpectomy, Mastectomy, Prognosis, Radiotherapy, Tamoxifen
Looking for this item?
Counterpart no longer offer a library service. We may be able to help you locate this item somewhere else. If you want help to find information, please call us on 1300 781 500 or send us an email. Our Resource Centre is open Monday, Wednesday and Thursday, from 10am to 5pm.
Last Updated: 6 February, 2014 8:55 am
